Skip to content

Gluteal trigger point injection in lumbosacral canal stenosis patients

A comparison between effectiveness of gluteal trigger injection with epidural steroid injection in lumbosacral canal stenosis patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190802044411N1
Enrollment
50
Registered
2020-11-26
Start date
2020-08-22
Completion date
Unknown
Last updated
2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lumbosacral canal stenosis. Intervertebral disc stenosis of neural canal of lumbar region

Interventions

Intervention 1: Intervention group: The group that received 80 mg Amp Methylprednisolon and 4 cc Amp Marcaine epidural injection with fluoroscopic guidance and then two weeks , four weeks, eight wee

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: Age : 40 to75 years old Being diagnosis with lumbar canal stenosis according to mri or edx Complaining low back pain , psudoclaudication , parestesia that no responsed to conservative treatment Gender: male or female

Exclusion criteria

Exclusion criteria: Infection involving lumbar spinal (brucella) Diabetes mellitus Rhumatological disorder(lupuse, gout) BMI more than 42 Pregnancy Malignancy Liver disease sensitivity reaction to test drug Malnutrition Peripheral neuropathy Bleeding disorder Galactosemia Radiculopathy

Design outcomes

Secondary

MeasureTime frame
Function of patient. Timepoint: two weeks, four weeks , eight weeks. Method of measurement: The Quebec Back Pain Disability Scale.

Primary

MeasureTime frame
Radicular low back pain. Timepoint: two weeks, four weeks, eight weeks. Method of measurement: Visual Analogue Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSana Sadat Khoshnazar

Shiraz University of Medical Sciences

Khoshnazar31@yahoo.com+98 71 3648 6787

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026